Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1CNS 1

Conditions

Neurofibromatosis 1 3Neurofibromatoses 3Neurofibroma, Plexiform 2Neurofibroma 2Glioma 2Oligodendroglioma 1Neurocytoma 1Neoplasms, Neuroepithelial 1NF1 1Melanoma 1Glioblastoma 1Ganglioneuroma 1Ganglioglioma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

mirdametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NF1 × mirdametinib × CNS × Clear all
NCT06159166 2026-04-13

Mirda

Johns Hopkins University

Phase 1/2 Recruiting
24 enrolled
CNSDermatologic

NF1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡